Leaders in Allergy, Asthma and Immune Disease Clinical Research
31/01/2025
A Pre-Screening Study to Conduct a Future Clinical Study in Participants Allergic to Common Ragweed (Ambrosia artemisiifolia).
This pre-screening study will identify and characterize a patient population with a history of ragweed-induced rhinoconjunctivitis who may benefit from treatment and potentially be included in future interventional studies.
Please click on the link below if you are interested in the study:
Learn about the VALIANT asthma study. This study is now enrolling adult
participants 18 to 75 years of age with severe asthma. Click to see study details
VALIANT Asthma studyIf you are interested in participating in this clinical trial, please fill out the contact form to speak to one of our Research Coordinators to find out if this study is right for you. The VALIANT studyThe VALIANT study is evaluating a study drug given every 12 weeks to adult par...
Be the first to know and let us send you an email when Red Maple Trials posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.
Red Maple Trials is specialty clinical research organization that focuses in the fields of study of allergy, asthma, and immunology. Red Maple Trials works with biopharmaceutical companies to deliver environmental exposure chamber studies as well as other specialty services such as clinical project management, medical support, protocol design, to name a few examples. We have a long history in clinical research and we hold ourselves to the highest standards in both quality and patient safety. Our team has delivered successfully and safely on over 240 clinical trials and we bring over 130 combined years of experience in our field.
What is a chamber study?
Chamber studies are a specialized type of environmental allergy study. They are usually done to test the safety and effectiveness of various investigational medications. The problem with most environmental allergy studies is that there is no way to know exactly how much allergen (pollen, pet dander, etc) a patient is exposed to over the course of a study. This can result in large variations in patient symptoms, and can make results and data unclear. However, in chamber studies, researchers can control exactly how much allergen patients are exposed to, making the results clearer and the data more reliable. Researchers do this by measuring the symptoms of patients in a “chamber” — a large room capable of controlling temperature, humidity and allergen concentration.
Are these studies safe?
Our team has been conducting clinical trials for over 30 years and bring a strong reputation to both our patients and our partners. Our facility was built to GMP standards and we have a stringent Code of Conduct, Good Clinical Practice (GCP) and Standard Operating Protocols that focus on patient safety, medical support, fire and emergency protocols, and ethical code of conduct. Each of our staff members is fully trained on a regular basis and we are active in ensuring both the safety and comfort of each study participant.
What is involved in participating in a study with Red Maple Trials?
This varies greatly depending on the study. In general however, studies involve patients coming in for a few appointments, where we would do various medical examinations (e.g. allergy testing, blood work, lung function testing, physical examination, etc.). Participation in a chamber study would also involve spending some time (usually 2-3 hours) in the Allergen Challenge TheatreTM or in the Naturalistic Exposure Chamber. Some studies would involve patients taking an investigational medication.
